Cancer Drugs Lift Earnings at Genentech
11th Jan 2006, 17:56 GMT
Genentech reported that fourth-quarter profit rose 64 percent on surging sales of its breast cancer drug Herceptin and other cancer medicines.
Cancer Drugs Lift Earnings at Genentech related news:
- Cancer drug sales lift Genentech quarterly profit (Reuters) — Yahoo! News: Earnings News
- Genentech's 4Q Earnings Meet Expectations — Bio-Technology News from StratCenter.com
- Genentech's Q4 earnings match analyst expectations — News -- SiliconValley.com
- Cancer drug sales lift Genentech quarterly profit — washingtonpost.com -
- Investors bail on Genentech after 4th-qtr earnings (Reuters) — Yahoo! News: Earnings News
- Genentech's 4Q Earnings Match Expectations (AP) — Yahoo! News: Earnings News
- Investors bail on Genentech after 4th-qtr earnings — washingtonpost.com -
- Genentech income rises 64% in quarter — News -- SiliconValley.com
- Genentech's fourth-quarter earnings match analyst expectations — SacBee -- Business
- Genentech Shares Sink After 4Q Report (AP) — Yahoo! News: Earnings News
Latest news from NYT > Business:
- The Media Equation: Dubious Mix: Rich Suitors, Ailing Papers
- KB Home Ousts Its Chief and 2 Others
- Shopping: Candles, Jeans, Lipsticks: Products With Ulterior Motives
- Robert B. McCurry, Auto Executive, Dies at 83
- G.E. and Hitachi to Merge Nuclear Businesses
- A Setback for Vietnam Trade Bill
- Hedge Manager Is Almost Famous
- With a Dish, Broadband Goes Rural
- Uneasy Days for Chiefs in Germany
- Steel Maker Says Its Plan to Sell Unit Is Blocked